Ostarine, Cardarine & SR-9009

(18-35 year old demographic)

LIQUID OSTARINE (MK-2866) – THE ULTIMATE GUIDE

Ostarine, also known as MK-2866, GTX-024, or Enobosarm, is one of the most well-researched and widely recognized selective androgen receptor modulators (SARMs). Originally developed in the late 1990s, Ostarine was designed as a potential treatment for conditions like osteoporosis, muscle wasting, and insulin resistance. Today, it remains a focal point of clinical research due to its unique ability to selectively target androgen receptors without the harsh side effects commonly associated with anabolic steroids, testosterone, or human growth hormone.

WHY OSTARINE STANDS OUT IN CLINICAL RESEARCH

Ostarine’s selective action makes it a promising candidate for research, particularly in female and elderly populations where traditional anabolic treatments may not be suitable. Studies have shown that Ostarine is generally well-tolerated, with doses of up to 18mg per day administered safely over 12 months in female cancer patients. Unlike many anabolic agents, Ostarine is orally bioavailable, eliminating the need for injections.

While Ostarine shows significant potential, it’s important to note that research is ongoing. Potential side effects, such as testosterone suppression in males and menstrual irregularities in females, are still being studied. Long-term effects and interactions with other substances remain under investigation.

POTENTIAL BENEFITS OF OSTARINE IN RESEARCH STUDIES

Research on Ostarine has highlighted several potential benefits, including:

• Enhanced muscle growth and strength
• Increased protein synthesis
• Improved bone density and health
• Accelerated recovery of connective tissues
• Reduction in body fat and support for weight loss
• Boosted energy levels
• Positive effects on heart health

It’s crucial to emphasize that Ostarine is not approved by the FDA for human consumption and is strictly intended for laboratory research purposes. It should not be confused with dietary supplements or sports performance enhancers.

KEY RESEARCH FINDINGS ON OSTARINE (MK-2866)

1. Muscle and Strength Benefits: A 2011 study demonstrated that Ostarine significantly increased lean body mass, muscle strength, and physical function in elderly men and postmenopausal women.
2. Bone Health: A 2019 study on ovariectomized rats found that Ostarine improved bone healing and stimulated muscle growth.
3. Fat Metabolism: Research on Wistar rats revealed that Ostarine reduced fat-mediating hormones like leptin, suggesting potential benefits for fat loss.
4. Osteoporosis Support: Another 2019 study showed that Ostarine increased bone mineral density and reduced osteoporosis symptoms in postmenopausal rat models.

POTENTIAL SIDE EFFECTS AND SAFETY CONSIDERATIONS

As one of the oldest and most studied SARMs, Ostarine has a well-documented profile. However, research is still uncovering its full range of effects. Potential side effects may include:

• Testosterone suppression in males
• Menstrual irregularities in females
• Possible liver strain or increased hematocrit levels
• Insomnia or lethargy in some cases

The FDA has issued warnings about the misuse of Ostarine, emphasizing that it is not approved for human use and may pose serious health risks if abused.

LIQUID OSTARINE (MK-2866) PRODUCT DETAILS

• CAS Number: 841205-47-8
• Molecular Formula: C19H14F3N3O3
• Molar Mass: 389.330 g/mol
• Half-Life: 24 hours
• Classification: Selective Androgen Receptor Modulator (SARM)

Product Specifications:

• 30ml liquid Ostarine per bottle
• Concentration: 25mg per milliliter
• Includes a graduated 1mL glass pipette for precise measurement
• UV-resistant glass bottle to minimize degradation
• Tamper-proof seal for safety during transit
• Less than 5% variance in concentration for consistent results
• Formulated to prevent evaporation during storage

Storage Instructions: Store in a cool, dry place away from direct sunlight to maintain optimal shelf life.

Disclaimer: This product is intended for laboratory research purposes only. It is not approved for human consumption, nor is it a dietary or sports supplement.

REFERENCES

1. Dalton JT, et al. (2011). The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women. PubMed.
2. Hoffmann DB, et al. (2019). Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis. PubMed.
3. Smith MR, et al. (2019). A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer. PubMed.
4. Effect of ostarine (enobosarm/GTX024) on adipocyte metabolism in Wistar rats. PubMed.

(18-35 year old demographic)

Liquid Cardarine (GW501516) Overview – Elitebiogenix.com

Cardarine, scientifically known as GW501516 or Endurobol, is a potent PPAR (peroxisome proliferator-activated receptor) agonist. This compound functions as a ligand-activated transcription factor, binding to receptors in skeletal muscle and adipose tissue, promoting lipid utilization and fat burning. PPARs are also integral to processes like inflammation regulation, glucose homeostasis, and cellular functions such as proliferation, differentiation, and apoptosis, hinting at potential anti-aging benefits [1].

PPARs are predominantly found in tissues with high metabolic activity, including skeletal muscle, liver, heart, kidneys, and intestines [13]. Although often mistakenly grouped with selective androgen receptor modulators (SARMs), GW501516 operates differently. It does not interact with androgen receptors or influence testosterone levels but plays a significant role in energy metabolism.

How Cardarine Works

Developed in the 1990s, Cardarine is also referred to as GW1516 and GSK-516. It exhibits strong affinity (Ki = 1 nM) and specificity for PPARδ, with over 1,000-fold selectivity compared to PPARα and PPARγ [5]. When GW501516 binds to PPARδ, it recruits the coactivator PGC-1α, forming a complex that enhances the expression of proteins involved in energy expenditure [6]. By activating AMP-activated protein kinase, Cardarine is believed to offer a range of experimental benefits, including:

• Boosting fatty acid oxidation and fat loss
• Reducing LDL (“bad”) cholesterol
• Increasing HDL (“good”) cholesterol
• Enhancing endurance and stamina
• Lowering inflammation
• Improving insulin sensitivity and glucose tolerance

The Role of PPAR Agonists

Research shows that PPAR activity helps preserve glucose for critical tissues like the brain while mobilizing fatty acids for muscle endurance [10]. PPARs also regulate temperature, inflammation, mitochondrial respiration, and tissue repair. Molecular studies indicate that PPARs control genes linked to lipid oxidation, mitochondrial biogenesis, and contractile proteins [10].

PPAR Effects During Fasting

PPARs are particularly active during fasting, when free fatty acids are released into the bloodstream. Studies on PPAR-null mice revealed that the absence of PPAR leads to elevated free fatty acids, lipid accumulation in the liver and heart, low blood sugar, reduced body temperature, ketone production, and premature death [14]. Mice adapt to fasting by upregulating PPAR genes, which enhance fatty acid uptake and oxidation [15].

Cardarine Research Findings

Numerous animal studies highlight Cardarine’s potential to improve energy metabolism and blood lipid profiles:

• A study on mice demonstrated that GW501516 enhances fatty acid oxidation and alleviates metabolic syndrome [1].
• Research on Kunming mice showed that PPAR activation significantly boosts running endurance [2].
• Another study found that PPARs prevent glucose depletion during exercise, delaying fatigue [3].
• In obese rhesus monkeys, GW501516 increased HDL and reduced VLDL, suggesting cardioprotective effects [6].
• Phase II clinical trials indicated Cardarine’s potential benefits for obesity, diabetes, dyslipidemia, and cardiovascular health, along with reduced inflammation [7, 8].
• A study on high-fructose-fed rats found that GW501516 lowered inflammation markers and upregulated genes involved in beta-oxidation [11].

Cardarine Side Effects

While Cardarine does not cause androgenic side effects like steroids, high doses (3mg/kg/day) in rats led to rapid cancer development in multiple organs [9]. Anecdotal reports suggest minimal side effects, but further research is needed to establish its safety profile. The FDA has not approved Cardarine for human use, and it is banned by the World Anti-Doping Agency (WADA) due to its endurance-enhancing properties [4].

Liquid Cardarine Specifications

• CAS Number: 317318-70-0
• Formula: C21H18F3NO3S2
• Molar Mass: 453.498 g/mol
• Half-Life: 16–24 hours
• Class: PPAR Agonist
• Storage: Store in a cool, dry place away from sunlight to maintain potency.

Product Details:

• 30ml liquid Cardarine per bottle (20mg/ml concentration)
• UV-resistant glass bottle to minimize degradation
• Tamper-proof seal for secure delivery
• Less than 5% concentration variance for consistency
• Formulated to prevent evaporation during storage

Important Note:
This product is strictly for laboratory research purposes and is not approved by the FDA for human consumption. Cardarine (GW501516) is not a dietary or sports supplement.

Scientific References:

1. Tanaka et al., Proc. Natl. Acad. Sci. U.S.A., 2003
2. Chen et al., Sci. Rep., 2015
3. Fan et al., Cell Metab., 2017
4. Sports Technology Labs, 2023
5. Oliver et al., Proc. Natl. Acad. Sci. U.S.A., 2001
6. Sprecher, Am J Cardiol., 2007
7. Barish et al., J Clin Invest., 2006
8. Dressel et al., Mol Endocrinol., 2003
9. Sahebkar et al., Expert Opin Pharmacother., 2014
10. Coll et al., Endocrinology, 2010
11. Magliano et al., Endocrine, 2015
12. Van Wagoner et al., JAMA, 2017
13. Burri et al., PPAR Res., 2010
14. Leone et al., Proc. Natl. Acad. Sci. U.S.A., 1999
15. Kersten et al., J Clin Invest., 1999

(18-35 year old demographic)

SR9009 (Liquid Stenabolic) – EliteBiogenix Research Compound Overview

EliteBiogenix is proud to provide premium-quality SR9009 (Liquid Stenabolic), a cutting-edge research compound designed for scientific exploration. SR9009 is a potent Rev-ErbA protein agonist, a protein expressed in key areas of the body, including the liver and skeletal muscle systems. Research indicates that SR9009 plays a significant role in regulating circadian rhythms, influencing lipid and glucose metabolism, and modulating fat-storing cells. While not classified as a SARM (Selective Androgen Receptor Modulator), SR9009 binds to Rev-ErbA, producing effects comparable to SARMs and beyond.

Developed in 2013 by Scripps Research, SR9009 has demonstrated remarkable potential in preclinical studies. Early research on mice revealed its ability to enhance metabolic activity, promote skeletal muscle growth, and support fat loss without impacting endogenous testosterone levels. For researchers seeking a high-quality compound for cutting-edge studies, EliteBiogenix is the trusted source to buy SR9009 online.

Key Research Findings on SR9009

SR9009 has shown a wide range of effects in preclinical studies, including:

• Boosted Resting Metabolic Rate: Enhances energy expenditure, supporting fat loss.
• Cardiovascular Protection: Promotes heart health and resilience under stress.
• Circadian Rhythm Regulation: Helps regulate sleep patterns and metabolic cycles.
• Improved Endurance: Increases exercise capacity and stamina.
• Weight Management: Supports fat reduction and lean muscle retention.
• Cholesterol Regulation: Lowers cholesterol levels for improved metabolic health.
• Anti-Inflammatory Properties: Reduces bodily inflammation.
• Arterial Health: Manages arterial plaque buildup.

SR9009 has also shown promise in addressing conditions such as heart failure, COPD (Chronic Obstructive Pulmonary Disease), and metabolic syndrome. However, further research on human subjects is required to fully understand its potential.

SR9009 and Circadian Rhythm

SR9009 has been shown to influence circadian behavior and gene expression in preclinical models. By targeting Rev-ErbA, it modulates metabolic genes in the liver, skeletal muscle, and adipose tissues, leading to increased energy expenditure. In studies involving diet-induced obese mice, SR9009 reduced fat mass, improved dyslipidemia, and normalized hyperglycemia. These findings suggest that SR9009 may hold potential for addressing sleep disorders and metabolic diseases linked to circadian rhythm disruptions.

SR9009 and Energy Metabolism

Research on SR9009 highlights its ability to regulate energy homeostasis. In studies involving goldfish, SR9009 inhibited feeding, reduced body weight, and lowered plasma glucose levels. It also decreased lipid levels and lipogenic enzyme activity while increasing glycolysis in the liver. These effects indicate that SR9009 promotes a negative energy balance by optimizing lipid and glucose metabolism, making it a compelling compound for metabolic research.

SR9009 and Endurance

A 2013 study demonstrated that mice treated with SR9009 exhibited significantly improved endurance, running longer distances and durations compared to untreated subjects. This effect is attributed to SR9009’s ability to increase mitochondrial density and enhance respiratory capacity. Unlike other endurance-enhancing compounds, SR9009 achieves this by regulating gene networks that govern mitochondrial function, offering a unique mechanism of action.

SR9009 and Cardiovascular Health

SR9009 has demonstrated cardio-protective properties in preclinical models. Studies on REV-ERB-deficient mice revealed that SR9009 could still protect the heart from pressure overload, even in the absence of REV-ERB proteins. This suggests that SR9009’s cardio-protective effects operate independently of REV-ERB, making it a valuable compound for cardiovascular research.

SR9009 and Lung Health

In vitro studies have shown that SR9009 can reduce inflammation in lung injury models by suppressing TLR4-induced NF-κB activation. It has also been shown to improve metabolic markers such as arterial PaCO2, PaO2, and blood pH, suggesting potential benefits for acute lung injury management. Additionally, SR9009 has demonstrated anti-tumor effects in small cell lung cancer (SCLC) models, making it a promising candidate for oncology research.

SR9009 (Liquid Stenabolic) Product Details

• CAS Number: 1379686-30-2
• Molecular Formula: C20H24ClN3O4S
• Molar Mass: 437.940 g/mol
• Classification: Rev-ErbA Agonist
• Storage: Store in a cool, dry place away from direct sunlight to maintain stability.

Product Specifications:

• 50ml liquid SR9009 per bottle
• Concentration: 20mg/ml
• Includes a graduated 1mL glass pipette for precise measurement
• UV-resistant glass bottle to minimize degradation
• Tamper-proof seal for secure delivery
• Less than 5% concentration variance for consistency
• Formulated to prevent evaporation during storage

Important Note: SR9009 is intended for laboratory research purposes only. It is not approved by the FDA for human consumption and should not be used as a dietary or sports supplement.

References

1. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature
2. Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nature
3. SR9009 improves heart function after pressure overload independent of cardiac REV-ERB. Frontiers in Cardiovascular Medicine
4. SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis. Hindawi
5. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy. NCBI
6. REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish. MDPI